News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
370,321 Results
Type
Article (23756)
Company Profile (128)
Press Release (346437)
Section
Business (116490)
Career Advice (1456)
Deals (20546)
Drug Delivery (92)
Drug Development (55476)
Employer Resources (111)
FDA (9289)
Job Trends (8901)
News (206680)
Policy (20586)
Tag
Academia (1130)
Africa (494)
Alliances (30916)
Alzheimer's disease (670)
Antibody-drug conjugate (ADC) (39)
Approvals (9264)
Arizona (50)
Artificial intelligence (56)
Asia (26474)
Australia (3717)
Bankruptcy (195)
Best Places to Work (6325)
Biosimilars (55)
Biotechnology (63)
C2C Services and Suppliers (20112)
California (839)
Canada (551)
Cancer (221)
Career advice (1192)
Cell therapy (50)
China (72)
Clinical research (44525)
Collaboration (71)
COVID-19 (1359)
Cystic fibrosis (45)
Data (85)
Diabetes (48)
Diagnostics (2391)
Drug pricing (72)
Earnings (41156)
Employer resources (97)
Europe (56318)
Events (51729)
Executive appointments (65)
FDA (9391)
Florida (103)
Funding (48)
Gene therapy (59)
GLP-1 (448)
Government (2544)
Healthcare (7969)
Hotbed/Location (249537)
Illinois (108)
Indiana (84)
Infectious disease (1376)
Inflammatory bowel disease (67)
Interviews (274)
IPO (8141)
Job creations (2629)
Job search strategy (1031)
Kansas (58)
Layoffs (279)
Legal (4538)
Liver cancer (36)
Lung cancer (48)
Manufacturing (69)
Maryland (154)
Massachusetts (694)
Medical device (3725)
Medtech (3726)
Mergers & acquisitions (12294)
Metabolic disorders (206)
Michigan (40)
Minnesota (70)
Neuroscience (752)
New Jersey (314)
New York (249)
NextGen Class of 2024 (2975)
Non-profit (1667)
North Carolina (311)
Northern California (402)
Obesity (134)
Ohio (54)
Opinion (178)
Patents (48)
Pennsylvania (259)
People (36037)
Pharmaceutical (62)
Phase I (13873)
Phase II (19132)
Phase III (15083)
Pipeline (67)
Podcasts (49)
Policy (54)
Postmarket research (1680)
Preclinical (4968)
Rare diseases (79)
Real estate (3612)
Recruiting (41)
Regulatory (14073)
Research institute (1174)
Resumes & cover letters (226)
South America (707)
Southern California (352)
Startups (2242)
Texas (93)
United States (3779)
Vaccines (226)
Washington State (106)
Weight loss (133)
Date
Last 7 days (266)
Last 30 days (1304)
Last 365 days (21726)
2024 (14140)
2023 (22927)
2022 (29762)
2021 (30876)
2020 (29585)
2019 (24400)
2018 (18891)
2017 (19648)
2016 (18590)
2015 (21477)
2014 (16712)
2013 (13977)
2012 (14992)
2011 (15541)
2010 (14018)
370,321 Results for "step pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D
The pharma giant announced Tuesday that Mikael Dolsten is leaving his role as chief science officer after more than 15 years. Pfizer is conducting an external search for a replacement with Dolsten staying on to assist in finding his replacement over next several months.
July 9, 2024
·
1 min read
·
Kate Goodwin
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
Business
InBrain Pharma Announces the Appointment of Dr Véronique Foutel as CEO
InBrain Pharma, a biotech specialized in brain infusion of drugs for neurological disorder management, announced the appointment of Dr. Véronique Foutel as CEO to drive the next company’s development steps.
February 27, 2024
·
4 min read
Genetown
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix, Inc. announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital.
April 19, 2024
·
2 min read
Leadership
Leadership Lab: 5 Steps for Building Your Personal Brand
By building and nurturing a strong personal brand, you can benefit in multiple ways, including enhancing your credibility, attracting opportunities and inspiring investor confidence.
August 19, 2024
·
5 min read
·
Michael Pietrack
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Pharm Country
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
Traws Pharma, Inc. announced presentation of a poster at the annual International Conference on Antiviral Research which is being held from May 20th to May 24th in Gold Coast, Australia.
May 23, 2024
·
6 min read
FDA
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
June 26, 2024
·
10 min read
Press Releases
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
July 17, 2024
·
4 min read
1 of 37,033
Next
